Cullinan Therapeutics Receives Approval to Initiate Its Global Phase 1 Clinical Trial of Cln-978
Cullinan Therapeutics獲批啓動其Cln-978全球第1期臨床試驗。
Cullinan Therapeutics Receives Approval to Initiate Its Global Phase 1 Clinical Trial of Cln-978
Cullinan Therapeutics獲批啓動其Cln-978全球第1期臨床試驗。
譯文內容由第三人軟體翻譯。